胸膜上皮瘤的医疗治疗:一个叙事评论
Qian Huang1, Lingling Zhu1, Yanyang Liu1
1Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China; Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, China.
Biochimica et biophysica acta. Reviews on cancer
|August 8, 2024
概括
本综述探讨了胸膜上皮瘤,重点关注化疗.
科学领域:
- 在瘤学瘤学.
- 胸部外科手术 胸部外科手术
背景情况:
- 胸膜上皮瘤是前中最常见的初级瘤,但整体来说很少见.
- 这些瘤被分类为胸腺瘤或胸腺癌.
- 手术是早期疾病的首要治疗方法;化学辐射疗法用于晚期,无法切除的病例.
研究的目的:
- 总结当前关于胸膜上皮瘤化疗的信息,包括新辅助和组合疗法.
- 审查现有治疗方法的有效性和针对性治疗的最新进展.
- 分析免疫检查点抑制剂对胸膜上皮瘤的疗效和安全性.
主要方法:
- 化学疗法,向疗法和免疫检查点抑制剂在胸膜上皮瘤中的综合文献综述.
- 对治疗有效性和安全性数据的分析.
- 综合信息,提供一个整体的治疗视角.
主要成果:
- 化疗,特别是新辅助疗法,仍然是关键的治疗方式.
- 向治疗在胸腺瘤中显示出有限的疗效.
- 免疫检查点抑制剂显示出潜力,但由于与免疫相关的不良影响而面临局限性,特别是在胸腺瘤中.
结论:
- 化疗和化疗辐射疗法是对胸膜上皮瘤的已知治疗方法.
- 针对性治疗的进展有限,需要进一步的研究.
- 免疫检查点抑制剂为晚期疾病提供了潜在的途径,但仔细管理副作用至关重要.
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Tumor Immunotherapy
497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497


